Coloplast A/S

COLOB-DC

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about COLOB-DC

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
April 1, 2020
(A Top Pick Jan 13/20, Up 21%) A Danish company specializing in incontinence and other medical products. A good defensive holding. They are expecting to cut revenues by 4-6%, but their margins are remaining strong as they commit to cut costs.
Show full opinionHide full opinion
(A Top Pick Jan 13/20, Up 21%) A Danish company specializing in incontinence and other medical products. A good defensive holding. They are expecting to cut revenues by 4-6%, but their margins are remaining strong as they commit to cut costs.
TOP PICK
TOP PICK
January 13, 2020
A Danish healthcare company that focuses on wound care, skin care, digestion and other areas. Smart managers continue to focus on R&D--he likes that. Since 2015, they've increased clinical studies by 2.5x and patents by 10x. They've spent free cash flow very well. Revenues have grown 9% annually even during the Great Recession. (Analysts’ price target is $10.74)
Show full opinionHide full opinion
Coloplast A/S (COLOB-DC)
January 13, 2020
A Danish healthcare company that focuses on wound care, skin care, digestion and other areas. Smart managers continue to focus on R&D--he likes that. Since 2015, they've increased clinical studies by 2.5x and patents by 10x. They've spent free cash flow very well. Revenues have grown 9% annually even during the Great Recession. (Analysts’ price target is $10.74)
PAST TOP PICK
PAST TOP PICK
October 12, 2018

(A Top Pick August 21/17, Up 24%) Colostomy bags and catheters, playing the aging demographic. Gained market share in US. Free cash flow is above competitors. Dividend grows about 10-15% per year. Investors go here to hide, so it goes up when markets go down. Buy on a pullback.

Show full opinionHide full opinion
Coloplast A/S (COLOB-DC)
October 12, 2018

(A Top Pick August 21/17, Up 24%) Colostomy bags and catheters, playing the aging demographic. Gained market share in US. Free cash flow is above competitors. Dividend grows about 10-15% per year. Investors go here to hide, so it goes up when markets go down. Buy on a pullback.

TOP PICK
TOP PICK
August 21, 2017

Colostomy bags. The demographics are such that gastrointestinal disorders are among the bigger problems dealing with the retirees of the world. If you get a company this size growing this fast without acquisitions you have a good company. They have a history of dividend increases. (Analysts’ target: DKK 553.00).

Show full opinionHide full opinion
Coloplast A/S (COLOB-DC)
August 21, 2017

Colostomy bags. The demographics are such that gastrointestinal disorders are among the bigger problems dealing with the retirees of the world. If you get a company this size growing this fast without acquisitions you have a good company. They have a history of dividend increases. (Analysts’ target: DKK 553.00).

Showing 1 to 4 of 4 entries
  • «
  • 1
  • »

Coloplast A/S(COLOB-DC) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for Coloplast A/S is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Coloplast A/S(COLOB-DC) Frequently Asked Questions

What is Coloplast A/S stock symbol?

Coloplast A/S is a OTC stock, trading under the symbol COLOB-DC on the (). It is usually referred to as or COLOB-DC

Is Coloplast A/S a buy or a sell?

In the last year, 1 stock analyst published opinions about COLOB-DC. 1 analyst recommended to BUY the stock. 0 analyst recommended to SELL the stock. The latest stock analyst recommendation is PAST TOP PICK. Read the latest stock experts' ratings for Coloplast A/S.

Is Coloplast A/S a good investment or a top pick?

Coloplast A/S was recommended as a Top Pick by Brett Girard, CPA, CA, CFA on 2020-04-01. Read the latest stock experts ratings for Coloplast A/S.

Why is Coloplast A/S stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Coloplast A/S worth watching?

1 stock analyst on Stockchase covered Coloplast A/S In the last year. It is a trending stock that is worth watching.

What is Coloplast A/S stock price?

On , Coloplast A/S (COLOB-DC) stock closed at a price of $.